CardiAQ Valve Technologies (CVT)
24 articles about CardiAQ Valve Technologies (CVT)
-
Neovasc Release: Company Announces Update In Litigation With CardiAQ Valve Technologies (CVT)
1/19/2017
-
Neovasc Announces Update in Litigation With CardiAQ Valve Technologies (CVT)
12/28/2016
-
Neovasc Avoids Lawsuit Over $70 Million Loss to CardiAQ Valve Technologies (CVT)
11/23/2016
-
Edwards Lifesciences Completes Acquisition Of CardiAQ Valve Technologies (CVT)
8/27/2015
-
Why Edwards Lifesciences CEO Bought CardiAQ Valve Technologies (CVT)
7/30/2015
-
CardiAQ Valve Technologies (CVT) Reports First-In-Human Percutaneous Transfemoral, Transseptal Implantation With Its Second Generation Transcatheter Bioprosthetic Mitral Heart Valve
6/23/2015
-
CardiAQ Valve Technologies (CVT) Receives FDA IDE Approval For A US Early Feasibility Study Of Its Second-Generation Transfemoral And Transapical Transcatheter Mitral Valve Implantation Systems
4/10/2015
-
CardiAQ Valve Technologies (CVT) Names Jack Lips And Steven Marmon As Clinical Specialist Manager And Clinical Trial Manager Respectively
11/24/2014
-
CardiAQ Valve Technologies (CVT) Announces That It Has Obtained A Stay Of Further Proceedings In Neovasc Inc.’S Pending European Patent Application Covering Transcatheter Mitral Valve Replacement
7/7/2014
-
CardiAQ Valve Technologies (CVT) Sues Neovasc Inc. For Fraud, Breach Of Contract, And Misappropriation Of Trade Secrets
6/9/2014
-
CardiAQ Valve Technologies (CVT) Completes $37.3 Million Series B Financing
11/29/2012
-
CardiAQ Valve Technologies (CVT) Raises $33 Million for Mitral Valve Replacement
11/7/2012
-
CardiAQ Valve Technologies (CVT) Offers New Hope for Cardiovascular Medicine
6/19/2012
-
CardiAQ Valve Technologies (CVT) Reports Cardiovascular Medicine Milestone: First-In-Humannonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve
6/14/2012
-
CardiAQ Valve Technologies (CVT) Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve
6/14/2012
-
CardiAQ Valve Technologies (CVT) Appoints Dr. Kalathi Thyagarajan as Vice President of Regulatory Affairs & Quality Assurance
2/9/2011
-
CardiAQ Valve Technologies (CVT) Appoints Rob Michiels as Chief Executive Officer
1/7/2011
-
CardiAQ Valve Technologies (CVT) to Present Latest in Vivo Results of its TranscatheterMitral Valve Implantation (TMVI) System on Wed., Sept. 22, at "TCT 2010"
9/21/2010
-
CardiAQ Completes Move of Its Headquarters to a Specialized Facility in Irvine, Calif., and Announces Expansion of Its Product Development Team
6/1/2010
-
CardiAQ Closes $6.5 Million ‘Series A’ Funding for Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
1/12/2010